FDA Inspection 1299038 — Dr. Vanda Salutari
The FDA completed an inspection of Dr. Vanda Salutari on December 12, 2025 in Rome. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 12, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rome (Italy)
Additional Details
Clinical Investigator (CI)